Patent classifications
A61K9/22
Methylphenidate extended release chewable tablet
An oral methylphenidate extended release tablet is described, which can be scored and still retain its extended release profile. The tablet contains a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and an uncomplexed methylphenidate active component. Following administration of a single dose of the extended release methylphenidate chewable tablet, a therapeutically effective amount of methylphenidate is reached in less than about 20 minutes and the composition provides a twelve-hour extended release profile.
Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
The present disclosure provides oral dosage forms comprising an antiplatelet agent and an enterically coated acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and an enterically coated acid inhibitor.
Enteral sustained-release sugar alcohol additive and preparation method and application thereof
An enteral sustained-release sugar alcohol additive including an inner layer structure and an outer layer structure is provided. The inner layer structure contains components of xylitol and agar, and the outer layer structure contains components of carrageenan or gellan gum or xanthan gum or guar gum, vitamin B12, L-arabinose, and fermented Bifidobacterium or fermented Propionibacterium or fermented Lactobacillus. A method of preparing an enteral sustained-release sugar alcohol additive and an application thereof are further provided.